
Keywords: LHRH; luteinizing hormone releasing hormone; ADT; androgen depletion therapy; CRPC; castration-resistant prostate cancer; CYP17; cytochrome P450 c17; MR; mineralocorticoid receptor; ER; estrogen receptor; PR; progestins receptor; GR; glucocorticoid recept